8-K ·Filed Apr 14, 2026

LMAT

LEMAITRE VASCULAR INC
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001193125-26-153779
8-K context-dependent: Items 5.02, 8.01
Actionable Insight • Neutral

Monitor the outcome of David B. Roberts' election at the 2026 Annual Meeting and assess any potential shifts in board dynamics, though no material governance concerns are indicated.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
LMAT ▼ -12.77% at T+60d
NEUTRAL call ✗ call lost -12.77% · α vs SPY -21.29% · entry $117.39 → $102.40
Entry anchored
Apr 13, 03:59 PM ET
via exchange tick
T+1d
-2.20%
call -2.20% · α -2.97%
$114.81
settled 6mo ago
T+5d
-4.68%
call -4.68% · α -6.07%
$111.90
settled 5mo ago
T+20d
-13.42%
call -13.42% · α -19.71%
$101.64
settled 5mo ago
T+60d
-12.77%
call -12.77% · α -21.29%
$102.40
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

LeMaitre Vascular announced director Bridget Ross will not stand for re-election at the 2026 Annual Meeting, and the board nominated David B. Roberts to fill the Class II seat. Concurrently, the company reduced its board size from eight to seven members effective upon Ross's departure. These changes are part of a board rebalancing effort with no indication of operational disagreements.

Key Facts

  • Director Bridget Ross notified the board on April 8, 2026, of her decision not to stand for re-election at the 2026 Annual Meeting.
  • David B. Roberts was nominated to stand for election as a Class II director, contingent on his conditional resignation as a Class I director.
  • The board size is being reduced from eight to seven members effective upon Ross's departure.
  • The company stated Ross's decision is not related to any disagreement with the company.

Financial Impact

No direct financial impact disclosed

board compositiongovernance structure

Risk Factors

  • Potential for minor governance disruption during transition
  • Uncertainty around Roberts' qualifications and future board balance

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-153779
Document: 0001193125-26-153779-index-headers.html0001193125-26-153779
Document: 0001193125-26-153779-index.html0001193125-26-153779
Document: 0001193125-26-153779.txt0001193125-26-153779
11 reports for LMAT
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +17.70%Jul 14, 2026
Filters
Rows
Reports for LMAT — sortable, filterable
TypeNow
Aug 27, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$80.45 $82.34▲ +2.35%▲ +2.09%$78.84 (−2.00%)
Jul 14, 2026
11w ago
Press Release
BEARISH ★ 7/10
$99.79 $82.13▲ +17.70%▲ +20.04%$78.84 (+20.99%)
May 7, 2026
21w ago
Insider Cluster
BEARISH ★ 4/10
$107.91 $91.64▲ +15.08%▲ +18.21%$78.84 (+26.94%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.84 (−26.94%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.84 (−26.94%)
May 5, 2026
21w ago
8-K
BULLISH ★ 7/10
$110.22 $91.64▼ −16.86%▼ −19.64%$78.84 (−28.47%)
Apr 14, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.84 (−32.84%)
Apr 14, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.84 (−32.84%)
Mar 11, 2026
29w ago
Insider Cluster
NEUTRAL ★ 3/10
$108.09 $112.71▲ +4.27%▲ +3.75%$78.84 (−27.06%)
Feb 26, 2026
31w ago
Insider Cluster
BEARISH ★ 7/10
$113.43 $110.33▲ +2.73%▼ −3.67%$78.84 (+30.49%)
Showing 10 of 11

US Market Status

Market Open — Closes in 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access